Page last updated: 2024-09-04

folligen and 9,10-dimethyl-1,2-benzanthracene

folligen has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Compound Research Comparison

Studies
(folligen)
Trials
(folligen)
Recent Studies (post-2010)
(folligen)
Studies
(9,10-dimethyl-1,2-benzanthracene)
Trials
(9,10-dimethyl-1,2-benzanthracene)
Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
5006,01010772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kéri, G; Nicholson, RI1

Other Studies

1 other study(ies) available for folligen and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Antitumour activity of folligen, a novel gonadotropin-releasing hormone analogue against DMBA-induced tumours in the rat.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1992, Volume: 13, Issue:1-2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Mammary Neoplasms, Experimental; Organ Size; Progesterone; Rats; Rats, Inbred Strains; Time Factors; Uterus

1992